Close Menu

NEW YORK (GenomeWeb) – Hologic said today that it has received two CE marks for its Aptima HIV-1 Quant Dx Assay for use in testing dried blood spots and the early diagnosis of the disease in infants.

Hologic said that as a result of receiving the CE marks, the assay can be used in European and African countries to qualitatively detect HIV type 1 (HIV-1) RNA in infants that are less than 18 months old. Clinicians in those countries can also use the assay in testing dried blood spots to monitor viral load and disease progression in HIV-1 infected patients.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.